Manhattan Bridge Capital (LOAN) 10-K 8 Mar 16 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 08, 2016	Jun. 30, 2015
Document Information [Line Items]
Entity Registrant Name	MANHATTAN BRIDGE CAPITAL, INC
Entity Central Index Key	1,080,340
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	LOAN
Entity Common Stock, Shares Outstanding		7,264,039
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 20,016,837

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 106,836	$ 47,676
Short term loans receivable	20,199,000	19,138,426
Interest receivable on loans	382,572	213,766
Other current assets	32,865	26,995
Total current assets	20,721,273	19,426,863
Long term loans receivable	10,705,040	4,894,050
Property and equipment, net	8,771	19,088
Security deposit	6,816	6,816
Investment in privately held company	50,000	65,000
Deferred financing costs	164,510	32,500
Total assets	31,656,410	24,444,317
Current liabilities:
Line of credit	11,821,099	7,700,000
Short term loans	1,095,620	2,469,465
Accounts payable and accrued expenses	99,643	163,622
Deferred origination fees	279,682	244,776
Dividends payable	617,443	0
Total liabilities, all current	$ 13,913,487	$ 10,577,863
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; no shares issued	$ 0	$ 0
Common shares - $.001 par value; 25,000,000 authorized; 7,441,039 and 6,260,689 issued; 7,264,039 and 6,083,689 outstanding	7,441	6,260
Additional paid-in capital	18,500,524	14,116,183
Treasury stock, at cost - 177,000	(369,335)	(369,335)
(Accumulated deficit) Retained earnings	(395,707)	113,346
Total stockholders’ equity	17,742,923	13,866,454
Total liabilities and stockholders’ equity	$ 31,656,410	$ 24,444,317

CONSOLIDATED BALANCE SHEETS _Pa

CONSOLIDATED BALANCE SHEETS [Parenthetical] - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	25,000,000	25,000,000
Common stock, shares issued	7,441,039	6,260,689
Common stock, shares outstanding	7,264,039	6,083,689
Treasury stock, shares	177,000	177,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Interest income from loans	$ 3,355,920	$ 2,401,150
Origination fees	644,706	502,515
Total Revenue	4,000,626	2,903,665
Operating costs and expenses:
Interest and amortization of debt service costs	691,392	563,368
Referral fees	2,356	2,244
General and administrative expenses	1,038,849	876,906
Total operating costs and expenses	1,732,597	1,442,518
Income from operations	2,268,029	1,461,147
Other income (Note 5)	0	21,197
Impairment loss on property and equipment (Note 6)	(13,863)	0
Loss on write-down of investment in privately held company (Note 7)	(15,000)	0
Total other (loss) income, net	(28,863)	21,197
Income before income tax expense	2,239,166	1,482,344
Income tax expense	(1,595)	(27,839)
Net income	$ 2,237,571	$ 1,454,505
Basic and diluted net income per common share outstanding:
Basic (in dollars per share)	$ 0.33	$ 0.29
Diluted (in dollars per share)	$ 0.33	$ 0.29
Weighted average number of common shares outstanding
Basic (in shares)	6,759,219	5,028,645
Diluted (in shares)	6,786,610	5,058,421

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2013	$ 8,892,687	$ 4,433	$ 9,745,249	$ (369,335)	$ (487,660)
Balance (in shares) at Dec. 31, 2013		4,433,190		177,000
Non cash compensation	28,767		28,767
Exercise of stock options	55,230	$ 67	55,163
Exercise of stock options (in shares)		66,887
Exercise of warrants	0	$ 6	(6)
Exercise of warrants (in shares)		6,226
Public offering	4,288,764	$ 1,754	4,287,010
Public offering (in shares)		1,754,386
Dividends paid	(853,499)				(853,499)
Net income for the year ended	1,454,505				1,454,505
Balance at Dec. 31, 2014	13,866,454	$ 6,260	14,116,183	$ (369,335)	113,346
Balance (in shares) at Dec. 31, 2014		6,260,689		177,000
Non cash compensation	13,664		13,664
Exercise of stock options	61,190	$ 40	61,150
Exercise of stock options (in shares)		40,000
Exercise of warrants	73,470	$ 21	73,449
Exercise of warrants (in shares)		20,350
Public offering	4,237,198	$ 1,120	4,236,078
Public offering (in shares)		1,120,000
Dividends paid	(2,129,181)				(2,129,181)
Dividends declared and payable	(617,443)				(617,443)
Net income for the year ended	2,237,571				2,237,571
Balance at Dec. 31, 2015	$ 17,742,923	$ 7,441	$ 18,500,524	$ (369,335)	$ (395,707)
Balance (in shares) at Dec. 31, 2015		7,441,039		177,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net Income	$ 2,237,571	$ 1,454,505
Adjustments to reconcile net income to net cash provided by operating activities -
Amortization of deferred financing costs	39,542	0
Depreciation	5,714	0
Non cash compensation expense	13,664	28,767
Impairment loss on property and equipment (Note 6)	13,863	0
Loss on write-down of investment in privately held company (Note 7)	15,000	0
Changes in operating assets and liabilities:
Interest receivable on loans	(168,806)	(42,283)
Other current and non current assets	(5,871)	(8,634)
Accounts payable and accrued expenses	(63,979)	106,556
Deferred origination fees	34,906	112,758
Income taxes payable	0	(373,219)
Net cash provided by operating activities	2,121,604	1,278,450
Cash flows from investing activities:
Issuance of short term loans	(21,609,000)	(22,585,990)
Collections received from loans	14,737,436	13,248,464
Proceeds from exercise of option (Note 5)	0	146,821
Purchase of fixed assets	(9,260)	(19,088)
Net cash used in investing activities	(6,880,824)	(9,209,793)
Cash flows from financing activities:
Proceeds from loans and line of credit, net	2,747,254	3,500,000
Proceeds from exercise of stock options and warrants	134,660	55,230
Proceeds from public offering, net	4,237,198	4,288,765
Dividends paid	(2,129,181)	(853,499)
Deferred financing costs incurred	(171,551)	(32,500)
Net cash provided by financing activities	4,818,380	6,957,996
Net increase (decrease) in cash and cash equivalents	59,160	(973,347)
Cash and cash equivalents, beginning of year	47,676	1,021,023
Cash and cash equivalents, end of year	106,836	47,676
Supplemental Cash Flow Information:
Taxes paid during the year	56	416,083
Interest paid during the year	596,187	563,368
Supplement Information - Noncash Information:
Dividend declared and payable	$ 617,443	$ 0

The Company

The Company	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation Of Financial Statements Disclosure [Text Block]	1. The Company Manhattan Bridge Capital, Inc. (“MBC”) and its wholly-owned subsidiaries DAG Funding Solutions, Inc. and MBC Funding II Corp. (collectively the “Company”), offer short-term, secured, non–banking loans (sometimes referred to as “hard money” loans) to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies The consolidated financial statements include the accounts of Manhattan Bridge Capital, Inc., and its wholly-owned subsidiaries DAG Funding Solutions, Inc.(“DAG Funding”) and MBC Funding II Corp. (“MBC Funding”). All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management will base the use of estimates on (a) a preset number of assumptions that consider past experience, (b) future projections, and (c) general financial market condition. Actual amounts could differ from those estimates. For the purposes of the statements of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash and cash equivalents with one major financial institution. Accounts at the financial institution are insured by the Federal Deposit Insurance Corporation up to $ 250,000 Credit risks associated with short term commercial loans the Company makes to small businesses and related interest receivable are described in Note 4 entitled Commercial Loans. The Company continually monitors events or changes in circumstances that could indicate carrying amounts of long lived assets, may not be recoverable. When such events or changes in circumstances occur, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted cash flows is less than the carrying amount of these assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. The Company accounts for income taxes under the provisions of FASB ASC 740, “Income Taxes”. Under the provisions of FASB ASC 740, deferred income taxes are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rate is recognized in income in the period that includes the enactment date. Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. The Company follows ASC 740 rules governing tax positions which provide guidance for recognition and measurement. This prescribes a threshold condition that a tax position must meet for any of the benefits of the uncertain tax position to be recognized in the financial statements. It also provides accounting guidance on derecognition, classification and disclosure of these uncertain tax positions. The Company is organized and conducts its operations to qualify as a real estate investment trust (“REIT”) for federal income tax purposes. The Company elected to be taxed as a REIT commencing with our taxable year ended December 31, 2014. A REIT calculates taxable income similar to other domestic corporations, with the major difference being a REIT is entitled to a deduction for dividends paid. A REIT is generally required to distribute each year at least 90% of its taxable income. If it chooses to retain the remaining 10% of taxable income, it may do so, but it will be subject to a corporate tax on such income. The Company may be subject to federal excise tax and minimum state taxes. The Company recognizes revenues in accordance with ASC 605, which provides guidance on the recognition, presentation and disclosure of revenue in financial statements. ASC 605 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery of the product has occurred or services have been rendered, (iii) the sales price charged is fixed or determinable, and (iv) collectability is reasonably assured. Interest income from commercial loans is recognized, as earned, over the loan period. Origination fee revenue on commercial loans is amortized over the term of the respective note. D proposed public offering of the Company’s securities and costs incurred in connection with the Company’s Webster Credit Line, as discussed in Note 8, which are being amortized over three years using the straight-line method Basic and diluted earnings per share are calculated in accordance with ASC 260 “Earnings Per Share”. Under ASC 260, basic earnings per share is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share include the potential dilution from the exercise of stock options and warrants for common shares using the treasury stock method. Years ended 2015 2014 Basic weighted average common shares outstanding 6,759,219 5,028,645 Incremental shares for assumed exercise of options 27,391 29,776 Diluted weighted average common shares outstanding 6,786,610 5,058,421 77,778 51,224 because their effect would have been anti-dilutive. The Company measures and recognizes compensation awards for all stock option grants made to employees and directors, based on their fair value in accordance with ASC 718 “Compensation - Stock Compensation”, which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. A key provision of this statement is to measure the cost of employee services received in exchange for an award of equity instruments (including stock options) based on the grant-date fair value of the award. The cost will be recognized over the service period during which an employee is required to provide service in exchange for the award (i.e., the requisite service period or vesting period). The Company accounts for equity instruments issued to non-employees in accordance with the provisions of ASC 718 and ASC 505-50, “Equity Based Payment to Non-Employees”. All transactions with non-employees, in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more appropriately measurable. For cash and cash equivalents, short term loans, the line of credit and accounts payable, as well as interest bearing commercial loans held by the Company, the carrying amount approximates fair value due to the relative short-term nature of such instruments. In January 2015, the FASB issued ASU 2015-01, “Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This ASU eliminates the separate presentation of extraordinary items but does not change the requirement to disclose material items that are unusual or infrequent in nature. The ASU is effective for fiscal years beginning after December 15, 2015, as well as interim periods within those fiscal years. The ASU may be applied retrospectively to all prior periods presented in the financial statements, and early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”. Under the ASU, an entity presents debt issuance costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. The ASU is effective for public entities for fiscal years beginning after December 15, 2015, and interim periods therein. For private companies and not-for-profit organizations, the ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In May 2015, the FASB issued ASU 2015-07, "Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) (a consensus of the Emerging Issues Task Force)". The ASU provides reporting entities with an option to measure the fair value of certain investments using net asset value instead of fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. For all other entities, the ASU is effective for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In August 2015, the FASB issued ASU 2015-15, “Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting”. The ASU incorporates the SEC staff's announcement that clarifies the exclusion of line-of-credit arrangements from the scope of ASU 2015-03. Therefore, debt issuance costs related to line-of-credit arrangements can be deferred and presented as an asset that is subsequently amortized over the time of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The ASU should be adopted concurrent with adoption of ASU 2015-03. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, “ Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”. The ASU simplifies the presentation of deferred income taxes by requiring deferred tax liabilities and assets to be classified as noncurrent in a classified statement of financial position. This Update will align the presentation of deferred income tax assets and liabilities with International Financial Reporting Standards (IFRS). For public business entities, the ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, the ASU is effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, “ ”. The ASU For public business entities, t For all other entities, Early adoption is permitted The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. Management does not believe that any other recently issued, but not yet effected, accounting standards if currently adopted would have a material effect on the Company’s consolidated financial statements.

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2015
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents Disclosure [Text Block]	3. Cash and Cash Equivalents Effective January 1, 2008, the Company adopted ASC 820, Fair Value Measurements, Level 1—Quoted prices in active markets. Level 2—Observable inputs other than quoted prices in active markets that are either directly or indirectly observable. Level 3—Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Cash equivalents and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy. The Company’s Level 1 investments are valued using quoted market prices in active markets. As of December 31, 2015 and 2014 the Company’s Level 1 investments consisted of cash and money market accounts in the amount of approximately $ 107,000 48,000

Commercial Loans

Commercial Loans	12 Months Ended
	Dec. 31, 2015
Commercial Loans [Abstract]
Commercial Loans [Text Block]	4. Commercial Loans Short Term Loans Receivable The Company offers short-term, secured, non–banking loans to real estate investors (also known as hard money) to fund their acquisition and construction of properties located in the New York Metropolitan area. The loans are principally secured by collateral consisting of real estate and, generally, accompanied by personal guarantees from the principals of the businesses. The loans are generally for a term of one year. The short term loans are initially recorded, and carried thereafter, in the financial statements at cost. Most of the loans provide for receipt of interest only during the term of the loan and a balloon payment at the end of the term. For the years ended December 31, 2015 and 2014 the total amounts of $ 21,609,000 and $ 22,585,990 14,737,436 13,248,464 14,000 1,475,000 the lower of (i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration) and (ii) $1.5 million. 12 15 1 3 In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value of the property 80 The Company uses its own employees, outside lawyers and other independent professionals to verify titles and ownership, to file liens and to consummate the transactions. Outside appraisers are also used to assist the Company’s officials in evaluating the worth of collateral. To date, the Company has not experienced any defaults and none of the loans previously made have been non-collectable, although no assurances can be given that existing or future loans may not go into default or prove to be non-collectible in the future. At December 31, 2015, the Company was committed to an additional $ 2,155,000 At December 31, 2015 and 2014, no one entity has loans outstanding representing more than 10% of the total balance of the loans outstanding. At December 31, 2015, two of the loans in the Company’s portfolio were jointly funded by the Company and unrelated entities, for aggregate loans of $ 1,835,000 1,230,000 At December 31, 2014, eight of the loans in the Company’s portfolio were jointly funded by the Company and unrelated entities, for aggregate loans of $ 5,105,000 2,665,000 The Company generally grants loans for a term of one year. When a performing loan reaches its maturity and the borrower requests an extension we may extend the term of the loan beyond one year and reclassify it as part of long term loans receivable. Prior to granting an extension of any loan, we reevaluate the underlying collateral. Long Term Loans Receivable Long term loans receivable comprise the loans that were extended beyond the original maturity dates, unless it is clear that the loan will be paid back by December 31, 2016. At December 31, 2015, the Company’s loan portfolio consists of $ 20,199,000 10,705,000 19,138,000 4,894,000 Credit Risk Performing loans Developers- Developers- Developers- Other Total outstanding December 31, 2015 $ 28,801,540 $ 1,000,000 $ 1,102,500 $ — $ 30,904,040 December 31, 2014 $ 22,360,040 $ 1,635,000 $ 20,000 $ 17,436 $ 24,032,476 At December 31, 2015, the Company’s long term loans receivable consists of loans in the amount of $ 179,050 100,000 225,000 2,525,000 7,675,990 179,050 100,000 120,000 570,000 3,925,000 respectively. In all instances the borrowers are currently paying their interest and, generally, the Company receives a fee in connection with the extension of the loans. Accordingly, at December 31, 2015 and 2014, no loan impairments exist and there are no provisions for impairments of loans or recoveries thereof included in operations for the years then ended. Subsequent to the balance sheet date, $ 6,155,000

Investment in Real Estate

Investment in Real Estate	12 Months Ended
	Dec. 31, 2015
Investment In Real Estate [Abstract]
Investment In Real Estate Disclosure [Text Block]	5. Investment in Real Estate Other income for the year ended December 31, 2014 in the amount of $ 21,197 146,821

Impairment Loss on Property and

Impairment Loss on Property and Equipment	12 Months Ended
	Dec. 31, 2015
Impairment Loss on Property and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	6. Impairment Loss on Property and Equipment During the year ended December 31, 2015, the Company determined to terminate the use of a computer software, resulting in an impairment loss in the amount of $ 13,863

Investment in Privately Held Co

Investment in Privately Held Company	12 Months Ended
	Dec. 31, 2015
Investments, All Other Investments [Abstract]
Cost-method Investments, Description [Text Block]	7. Investment in Privately Held Company The Company had an original investment in a privately held Israeli-based company in the amount of $ 100,000 65,000 50,000 15,000

Loans and Lines of Credit

Loans and Lines of Credit	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Loans And Line Of Credit [Text Block]	8. Loans and Lines of Credit Short Term Loans At December 31, 2014, the Company owed an aggregate of $ 2,419,465 8 12 160,000 10 16,000 In addition, 50,000 6 At December 31, 2015, the Company owed an aggregate of $ 1,095,620 8 12 335,000 10 31,118 During 2014, the Company received four separate short-term loans from three different entities in the aggregate amount of $ 2,100,000 12 14 seven separate loans from Mr. Ran in amounts ranging from $ 50,000 250,000 6 100,000 200,000 1,100,000 from Mr. Ran with the exception of 50,000 5,867 During 2015, 410,000 12 1,050,000 6 from Mr. Ran in the aggregate amount of $ 1,100,000 including the $50,000 outstanding balance remaining from 2014 8,817 the outstanding balances on other short term loans in the aggregate amount of $ 1,733,845 8 12 Subsequent to the balance sheet date, the Company fully repaid the outstanding balance on one of its short-term loans in the amount of $ 235,000 12 As a result, the remaining its short-term loans is currently 860,620 Lines of Credit On February 27, 2015, the Company entered into a Line of Credit Agreement with Webster Business Credit Corporation (“Webster”) pursuant to which it may borrow up to $ 14 39,542 The Webster Credit Line replaced the $ 7.7 1,100,000 1,000,000 12 11,821,099 The interest rate on the amount outstanding fluctuates daily. The rate for December 31, 2015 was 5.1739 %.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	9. Income Taxes 2015 2014 Current Taxes: Federal (refund) $ (1,137) $ 8,539 State 2,732 19,300 Income tax expense $ 1,595 $ 27,839 The income tax expense for the year ended December 31, 2014, represents the under accrual of the prior year's income tax expense. The Company had a capital loss carryover of $ 390,609 21,197 2015 The Company evaluates tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more likely than not” of being sustained by the applicable tax authorities. Tax positions not deemed to meet the more likely than not threshold are recorded as tax benefits or expenses in the current year. Management has analyzed the Company’s tax positions taken on Federal, state and local tax returns for all open tax years, and has concluded that no provision for Federal income tax is required in the Company’s financial statements. The Company elected to be taxed as a REIT commencing with its taxable year ended December 31, 2014. A REIT calculates taxable income similar to other domestic corporations, with the major difference being a REIT is entitled to a deduction for dividends paid. A REIT is generally required to distribute each year at least 90% of its taxable income. If it chooses to retain the remaining 10% of taxable income, it may do so, but it will be subject to a corporate tax on such income. The Company may be subject to federal excise tax and minimum state taxes. The Company is no longer subject to U.S. federal and state and local income tax examinations by tax authorities for years prior to 2012, as these tax years are closed.

Simple IRA Plan

Simple IRA Plan	12 Months Ended
	Dec. 31, 2015
Simple Ira Plan Abstract [Abstract]
Simple Ira Plan Disclosure [Text Block]	10. Simple IRA Plan On October 26, 2000, the board of directors approved a Simple IRA Plan (the “IRA Plan”) for the purpose of attracting and retaining valuable executives. The IRA Plan allows for participation by up to 100 12,500 3 10,500 9,734

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block]	Stock-Based Compensation On June 23, 2009 the Company adopted the 2009 Stock Option Plan (the “Plan”) and replaced the 1999 Stock Option Plan as amended (the “Prior Plan”), which expired in May of 2009. All options granted under the Prior Plan were expired, exercised or cancelled. The purpose of the Plan is to align the interests of officers, other key employees, consultants and non-employee directors of the Company and its subsidiary with those of the stockholders of the Company, to afford an incentive to such officers, employees, consultants and directors to continue as such, to increase their efforts on behalf of the Company and to promote the success of the Company’s business. The availability of additional shares will enhance the Company’s ability to achieve these goals. The basis of participation in the Plan is discretionary grants by the board of directors. The board of directors may at any time, and from time to time, suspend or terminate the Plan in whole or in part or amend it from time to time. A maximum of 400,000 376,000 224,000 248,000 The exercise price of options granted under the Plan may not be less than the fair market value on the date of grant. Stock options under the Plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Share based compensation expense recognized under ASC 718 for the years ended December 31, 2015 and 2014 were $ 13,664 28,767 The share based compensation expense for each of the years ended December 31, 2015 and 2014 includes 13,065 amortization of the fair value of 1,000,000 restricted shares granted to the Company's CEO on September 9, 2011 195,968 , after adjusting for the effect on the fair value of the stock options related to this transaction 15 The fair value of each option is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average share assumptions used for grants in 2014: (1) expected life of 5 9.59 59.5 1.71 Number of Weighted Weighted Aggregate Outstanding at January 1, 2014 285,000 $ 0.97 1.43 $ 147,656 Granted in 2014 21,000 2.92 Exercised in 2014 (77,000) 1.18 Forfeited or expired in 2014 (147,000) 0.75 Outstanding at December 31, 2014 82,000 $ 1.68 2.68 $ 59,115 Exercised in 2015 (40,000) 1.53 Forfeited or expired in 2015 (7,000) 1.34 Outstanding at December 31, 2015 35,000 $ 1.92 2.35 $ 24,876 Vested and exercisable at December 31, 2014 81,000 $ 1.69 2.69 $ 58,515 Vested and exercisable at December 31, 2015 35,000 $ 1.92 2.35 $ 24,876 The weighted-average fair value of options granted during the year ended December 31, 2014, estimated as of the grant date using the Black-Scholes option-pricing model, were $ 0.72 Stock Option Outstanding Exercisable Range of Exercise Number of Weighted Weighted Number of Weighted $ 1.01- $ 2.00 21,000 $ 1.25 1.58 21,000 $ 1.25 $ 2.01- $ 3.00 14,000 2.92 3.50 14,000 2.92 35,000 $ 1.92 2.35 35,000 $ 1.92 In connection with the Company’s private placement of senior secured notes, the Company issued 20,000 2.50 . exercisable over a five-year period. In December 2014, the Placement Agent exercised the warrant for all 20,000 common shares using the cashless exercise option under the warrant in lieu of paying cash in satisfaction of the exercise price, pursuant to which the Placement Agent received a lesser number of common shares. As a result, the Company issued 6,226 On July 31, 2014, in connection with the Company’s public offering in July 2014, the Company issued warrants to purchase 87,719 3.5625 July 28, 2019 42,224 17,550 On May 29, 2015, in connection with the Company’s public offering in May 2015, the Company issued warrants to purchase 50,750 5.4875 May 22, 2020 54,928

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	12. Stockholders’ Equity On July 31, 2014, the Company completed a public offering of 1,754,386 2.85 5,000,000 4,289,000 45 263,157 On May 29, 2015, the Company completed another public offering of 1,015,000 4.39 4,460,000 45 152,250 105,000 460,000 4,920,000 47,250 4,240,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	13. Commitments and Contingencies Operating Leases On June 9, 2011, the Company entered into a new lease agreement (the “Lease’) to relocate its corporate headquarters to 60 Cutter Mill Road, Great Neck, New York. The Lease is for a term of five years and two months 2,800 3,200 At December 31, 2015, approximate future minimum rental, including utilities, payments under these commitments are $ 28,100 Rent expense, including utilities, was approximately $ 42,000 Employment Agreements In March 1999, we entered into an employment agreement with Assaf Ran, our President and Chief Executive Officer pursuant to which: (i) Mr. Ran’s employment term renews automatically on June 30th of each year for successive one-year periods unless either party gives to the other written notice at least 180 days prior to June 30th of its intention to terminate the agreement; (ii) Mr. Ran receives an annual base salary of $225,000 and annual bonuses as determined by the Compensation Committee of the board of directors, in its sole and absolute discretion, and is eligible to participate in all executive benefit plans established and maintained by us; and (iii) Mr. Ran agreed to a one-year non-competition period following the termination of his employment. Mr. Ran’s annual base compensation was $ 225,000 65,000 35,000

Significant Accounting Polici20

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	The consolidated financial statements include the accounts of Manhattan Bridge Capital, Inc., and its wholly-owned subsidiaries DAG Funding Solutions, Inc.(“DAG Funding”) and MBC Funding II Corp. (“MBC Funding”). All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management will base the use of estimates on (a) a preset number of assumptions that consider past experience, (b) future projections, and (c) general financial market condition. Actual amounts could differ from those estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents For the purposes of the statements of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash and cash equivalents with one major financial institution. Accounts at the financial institution are insured by the Federal Deposit Insurance Corporation up to $ 250,000 Credit risks associated with short term commercial loans the Company makes to small businesses and related interest receivable are described in Note 4 entitled Commercial Loans.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long- lived assets The Company continually monitors events or changes in circumstances that could indicate carrying amounts of long lived assets, may not be recoverable. When such events or changes in circumstances occur, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the undiscounted cash flows is less than the carrying amount of these assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.
Income Tax, Policy [Policy Text Block]	The Company accounts for income taxes under the provisions of FASB ASC 740, “Income Taxes”. Under the provisions of FASB ASC 740, deferred income taxes are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rate is recognized in income in the period that includes the enactment date. Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. The Company follows ASC 740 rules governing tax positions which provide guidance for recognition and measurement. This prescribes a threshold condition that a tax position must meet for any of the benefits of the uncertain tax position to be recognized in the financial statements. It also provides accounting guidance on derecognition, classification and disclosure of these uncertain tax positions. The Company is organized and conducts its operations to qualify as a real estate investment trust (“REIT”) for federal income tax purposes. The Company elected to be taxed as a REIT commencing with our taxable year ended December 31, 2014. A REIT calculates taxable income similar to other domestic corporations, with the major difference being a REIT is entitled to a deduction for dividends paid. A REIT is generally required to distribute each year at least 90% of its taxable income. If it chooses to retain the remaining 10% of taxable income, it may do so, but it will be subject to a corporate tax on such income. The Company may be subject to federal excise tax and minimum state taxes.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenues in accordance with ASC 605, which provides guidance on the recognition, presentation and disclosure of revenue in financial statements. ASC 605 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery of the product has occurred or services have been rendered, (iii) the sales price charged is fixed or determinable, and (iv) collectability is reasonably assured. Interest income from commercial loans is recognized, as earned, over the loan period. Origination fee revenue on commercial loans is amortized over the term of the respective note.
Deferred Financing Costs [Policy Text Block]	D proposed public offering of the Company’s securities and costs incurred in connection with the Company’s Webster Credit Line, as discussed in Note 8, which are being amortized over three years using the straight-line method
Earnings Per Share, Policy [Policy Text Block]	Earnings Per Share (“EPS”) Basic and diluted earnings per share are calculated in accordance with ASC 260 “Earnings Per Share”. Under ASC 260, basic earnings per share is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share include the potential dilution from the exercise of stock options and warrants for common shares using the treasury stock method. Years ended 2015 2014 Basic weighted average common shares outstanding 6,759,219 5,028,645 Incremental shares for assumed exercise of options 27,391 29,776 Diluted weighted average common shares outstanding 6,786,610 5,058,421 77,778 51,224 because their effect would have been anti-dilutive.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company measures and recognizes compensation awards for all stock option grants made to employees and directors, based on their fair value in accordance with ASC 718 “Compensation - Stock Compensation”, which establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. A key provision of this statement is to measure the cost of employee services received in exchange for an award of equity instruments (including stock options) based on the grant-date fair value of the award. The cost will be recognized over the service period during which an employee is required to provide service in exchange for the award (i.e., the requisite service period or vesting period). The Company accounts for equity instruments issued to non-employees in accordance with the provisions of ASC 718 and ASC 505-50, “Equity Based Payment to Non-Employees”. All transactions with non-employees, in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more appropriately measurable.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments For cash and cash equivalents, short term loans, the line of credit and accounts payable, as well as interest bearing commercial loans held by the Company, the carrying amount approximates fair value due to the relative short-term nature of such instruments.
New Accounting Pronouncements, Policy [Policy Text Block]	In January 2015, the FASB issued ASU 2015-01, “Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This ASU eliminates the separate presentation of extraordinary items but does not change the requirement to disclose material items that are unusual or infrequent in nature. The ASU is effective for fiscal years beginning after December 15, 2015, as well as interim periods within those fiscal years. The ASU may be applied retrospectively to all prior periods presented in the financial statements, and early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”. Under the ASU, an entity presents debt issuance costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. The ASU is effective for public entities for fiscal years beginning after December 15, 2015, and interim periods therein. For private companies and not-for-profit organizations, the ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In May 2015, the FASB issued ASU 2015-07, "Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) (a consensus of the Emerging Issues Task Force)". The ASU provides reporting entities with an option to measure the fair value of certain investments using net asset value instead of fair value. The ASU is effective for public entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. For all other entities, the ASU is effective for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In August 2015, the FASB issued ASU 2015-15, “Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting”. The ASU incorporates the SEC staff's announcement that clarifies the exclusion of line-of-credit arrangements from the scope of ASU 2015-03. Therefore, debt issuance costs related to line-of-credit arrangements can be deferred and presented as an asset that is subsequently amortized over the time of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The ASU should be adopted concurrent with adoption of ASU 2015-03. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, “ Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”. The ASU simplifies the presentation of deferred income taxes by requiring deferred tax liabilities and assets to be classified as noncurrent in a classified statement of financial position. This Update will align the presentation of deferred income tax assets and liabilities with International Financial Reporting Standards (IFRS). For public business entities, the ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, the ASU is effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, “ ”. The ASU For public business entities, t For all other entities, Early adoption is permitted The adoption of this guidance is not expected to have a material impact on the Company’s consolidated financial statements. Management does not believe that any other recently issued, but not yet effected, accounting standards if currently adopted would have a material effect on the Company’s consolidated financial statements.

Significant Accounting Polici21

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Schedule of Weighted Average Number of Shares [Table Text Block]	The numerator in calculating both basic and diluted earnings per common share for each year is the reported net income. The denominator is based on the following weighted average number of common shares: Years ended 2015 2014 Basic weighted average common shares outstanding 6,759,219 5,028,645 Incremental shares for assumed exercise of options 27,391 29,776 Diluted weighted average common shares outstanding 6,786,610 5,058,421

Commercial Loans (Tables)

Commercial Loans (Tables)	12 Months Ended
	Dec. 31, 2015
Commercial Loans [Abstract]
Schedule of Debt [Table Text Block]	Credit risk profile based on loan activity as of December 31, 2015 and 2014: Performing loans Developers- Developers- Developers- Other Total outstanding December 31, 2015 $ 28,801,540 $ 1,000,000 $ 1,102,500 $ — $ 30,904,040 December 31, 2014 $ 22,360,040 $ 1,635,000 $ 20,000 $ 17,436 $ 24,032,476

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Income tax expense consists of the following: 2015 2014 Current Taxes: Federal (refund) $ (1,137) $ 8,539 State 2,732 19,300 Income tax expense $ 1,595 $ 27,839

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following summarizes stock option activity for the years ended December 31, 2015 and 2014: Number of Weighted Weighted Aggregate Outstanding at January 1, 2014 285,000 $ 0.97 1.43 $ 147,656 Granted in 2014 21,000 2.92 Exercised in 2014 (77,000) 1.18 Forfeited or expired in 2014 (147,000) 0.75 Outstanding at December 31, 2014 82,000 $ 1.68 2.68 $ 59,115 Exercised in 2015 (40,000) 1.53 Forfeited or expired in 2015 (7,000) 1.34 Outstanding at December 31, 2015 35,000 $ 1.92 2.35 $ 24,876 Vested and exercisable at December 31, 2014 81,000 $ 1.69 2.69 $ 58,515 Vested and exercisable at December 31, 2015 35,000 $ 1.92 2.35 $ 24,876
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	The following table summarizes information about stock options outstanding at December 31, 2015: Stock Option Outstanding Exercisable Range of Exercise Number of Weighted Weighted Number of Weighted $ 1.01- $ 2.00 21,000 $ 1.25 1.58 21,000 $ 1.25 $ 2.01- $ 3.00 14,000 2.92 3.50 14,000 2.92 35,000 $ 1.92 2.35 35,000 $ 1.92

Significant Accounting Polici25

Significant Accounting Policies (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Basic weighted average common shares outstanding	6,759,219	5,028,645
Incremental shares for assumed exercise of options	27,391	29,776
Diluted weighted average common shares outstanding	6,786,610	5,058,421

Significant Accounting Polici26

Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Significant Accounting Policies [Line Items]
Cash, FDIC Insured Amount	$ 250,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Vested Options and Warrants	77,778	51,224

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details Textual) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash and Cash Equivalents [Line Items]
Cash and Cash Equivalents, at Carrying Value, Total	$ 106,836	$ 47,676	$ 1,021,023

Commercial Loans (Details)

Commercial Loans (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Performing loans	$ 30,904,040	$ 24,032,476
Developers Residential [Member]
Debt Instrument [Line Items]
Performing loans	28,801,540	22,360,040
Developers Commercial [Member]
Debt Instrument [Line Items]
Performing loans	1,000,000	1,635,000
Developers Mixed Used [Member]
Debt Instrument [Line Items]
Performing loans	1,102,500	20,000
Other [Member]
Debt Instrument [Line Items]
Performing loans	$ 0	$ 17,436

Commercial Loans (Details Textu

Commercial Loans (Details Textual) - USD ($)	2 Months Ended	12 Months Ended
	Feb. 29, 2016	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Jointly Funded Loans Total		$ 1,835,000	$ 5,105,000
Jointly Funded Loans		1,230,000	2,665,000
Short Term Loans Receivable		20,199,000	19,138,426
Long Term Loans Receivable		10,705,040	4,894,050
Issuance Of Short Term Loans		21,609,000	22,585,990
Collections Received From Loans		$ 14,737,436	13,248,464
Short Term Loans Receivable, Limitation on Face Amount Description		the lower of (i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration) and (ii) $1.5 million.
Acquisition financing [Member]
Debt Instrument [Line Items]
Short Term Loans Receivable, Loan-to-value Ratio		In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value of the property
Construction Financing [Member]
Debt Instrument [Line Items]
Short Term Loans Receivable, Loan-to-value Ratio		in the case of construction financing, up to 80% of construction costs
Minimum [Member]
Debt Instrument [Line Items]
Loans Receivable Fixed Rates Of Interest		12.00%
Loans and Leases Receivable, Face Amount		$ 14,000
Origination Fees ,Percentage of Principal amount of the loan		1.00%
Maximum [Member]
Debt Instrument [Line Items]
Loans Receivable Fixed Rates Of Interest		15.00%
Loans and Leases Receivable, Face Amount		$ 1,475,000
Origination Fees ,Percentage of Principal amount of the loan		3.00%
Construction Loans [Member]
Debt Instrument [Line Items]
Short Term Loans Receivable Additional Borrowing Capacity		$ 2,155,000
Subsequent Event [Member] | Commercial Loan [Member]
Debt Instrument [Line Items]
Collections Received From Loans	$ 6,155,000
Due In 2009 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable		179,050	179,050
Due In 2010 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable		100,000	100,000
Due In 2011 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable			120,000
Due In 2013 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable		225,000	570,000
Due In 2014 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable		2,525,000	$ 3,925,000
Due In 2015 [Member]
Debt Instrument [Line Items]
Long Term Loans Receivable		$ 7,675,990

Investment in Real Estate (Deta

Investment in Real Estate (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Oct. 02, 2014
Investment in Real Estate Disclosure [Line Items]
Other Nonoperating Income	$ 0	$ 21,197
Buy Back Option [Member]
Investment in Real Estate Disclosure [Line Items]
Exercise Price Of Remaining Property			$ 146,821

Impairment Loss on Property a31

Impairment Loss on Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Impairment Loss on Property and Equipment [Line Items]
Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss	$ 13,863	$ 0

Investment in Privately Held 32

Investment in Privately Held Company (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Dec. 31, 2013
Investment In Privately Held Company [Line Items]
Cost Method Investments	$ 50,000	$ 65,000	$ 50,000	$ 65,000
Cost-method Investments, Other than Temporary Impairment	15,000	$ 0
Privately Held Company [Member]
Investment In Privately Held Company [Line Items]
Cost Method Investments, Original Cost	$ 100,000

Loans and Lines of Credit (Deta

Loans and Lines of Credit (Details Textual) - USD ($)	1 Months Ended	2 Months Ended	12 Months Ended
	Feb. 27, 2015	Feb. 29, 2016	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2015	Jan. 31, 2015	Dec. 31, 2011
Debt Instrument [Line Items]
Short-term Loans			$ 1,095,620	$ 2,469,465
Amortization of Financing Costs			$ 39,542	0
Repayments of Debt				$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage			12.00%	12.00%
Line Of Credit, Current			$ 11,821,099	$ 7,700,000
Sterling Credit Line [Member]
Debt Instrument [Line Items]
Replacement of Line of Credit Facility			7,700,000
Chief Executive Officer [Member]
Debt Instrument [Line Items]
Short-term Loans				50,000
Interest Expense, Related Party				5,867
Repayments of Debt			$ 1,100,000
Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Short-term Debt [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				200,000			$ 100,000
Repayments of Debt				$ 1,100,000
Repayments of Short-term Debt			$ 1,733,845
Short-term Debt [Member] | Chief Executive Officer [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount						$ 1,050,000
Interest Expense, Related Party	$ 8,817
Debt Instrument, Interest Rate, Stated Percentage				6.00%		6.00%
Repayments of Short-term Debt	1,100,000
Short-term Debt [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%	12.00%	12.00%
Short-term Debt [Member] | Maximum [Member] | Chief Executive Officer [Member]
Debt Instrument [Line Items]
Short-term Loans				$ 250,000
Short-term Debt [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			8.00%	8.00%
Short-term Debt [Member] | Minimum [Member] | Chief Executive Officer [Member]
Debt Instrument [Line Items]
Short-term Loans				$ 50,000
Line of Credit [Member]
Debt Instrument [Line Items]
Amortization of Financing Costs			$ 39,542
Line of Credit [Member] | Webster [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 14,000,000
Line of Credit Facility, Interest Rate Description	interest rate of either LIBOR plus 4.75% or the base commercial lending rate of Webster plus 3.25%
Line Of Credit, Current			$ 11,821,099
Debt Issuance Cost	$ 144,000
Line of Credit Facility, Interest Rate at Period End			5.1739%
Subsequent Event [Member]
Debt Instrument [Line Items]
Repayments of Short-term Debt		$ 235,000
Short Term Loans [Member]
Debt Instrument [Line Items]
Proceeds from Short-term Debt, Total			$ 410,000	$ 2,100,000
Short Term Loans [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				14.00%
Short Term Loans [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Short Term Loans [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Short-term Loans		$ 860,620
Mr. Ran [Member] | Short Term Loans [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 50,000
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Director [Member] | Short-term Debt [Member]
Debt Instrument [Line Items]
Short-term Loans			335,000	$ 160,000
Interest Expense, Related Party			$ 31,118	$ 16,000
Debt Instrument, Interest Rate, Stated Percentage			10.00%	10.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Current Taxes:
Federal (refund)	$ (1,137)	$ 8,539
State	2,732	19,300
Income tax expense	$ 1,595	$ 27,839

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Line Items]
Other Nonoperating Income	$ 0	$ 21,197
Capital Loss Carryforward [Member]
Income Tax Disclosure [Line Items]
Tax Credit Carryforward, Amount		$ 390,609
Other Tax Carryforward, Expiration Dates 1		2,015

Simple IRA Plan (Details Textua

Simple IRA Plan (Details Textual) - August 2000 [Member]	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Simple IRA Plan [Line Items]
Defined Contribution Plan, Number of Employees Covered	100
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount	$ 12,500
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%
Defined Contribution Plan Employer Matching Contribution Amount	$ 10,500	$ 9,734

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - Employee Stock Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding, Beginning balance	82,000	285,000
Number of Shares, Granted		21,000
Number of Shares, Exercised	(40,000)	(77,000)
Number of Shares, Forfeited or expired	(7,000)	(147,000)
Number of Shares, Outstanding, Ending balance	35,000	82,000	285,000
Number of Shares, Vested and exercisable	35,000	81,000
Weighted Average Exercise Price, Outstanding, Beginning balance (in dollars per share)	$ 1.68	$ 0.97
Weighted Average Exercise Price, Granted (in dollars per share)		2.92
Weighted Average Exercise Price, Exercised (in dollars per share)	1.53	1.18
Weighted Average Exercise Price, Forfeited or expired (in dollars per share)	1.34	0.75
Weighted Average Exercise Price, Outstanding, Ending balance (in dollars per share)	1.92	1.68	$ 0.97
Weighted Average Exercise Price, Vested and exercisable (in dollars per share)	$ 1.92	$ 1.69
Weighted Average Remaining Contractual Term Outstanding (in years)	2 years 4 months 6 days	2 years 8 months 5 days	1 year 5 months 5 days
Weighted Average Remaining Contractual Term Vested and exercisable (in years)	2 years 4 months 6 days	2 years 8 months 8 days
Aggregate Intrinsic Value, Outstanding (in dollars)	$ 24,876	$ 59,115	$ 147,656
Aggregate Intrinsic Value, Vested and exercisable (in dollars)	$ 24,876	$ 58,515

Stock-Based Compensation (Det38

Stock-Based Compensation (Details 1)	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Outstanding, Number of Shares (in shares) | shares	35,000
Stock Option Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.92
Stock Option Outstanding, Weighted Average Remaining Contractual Term (in years)	2 years 4 months 6 days
Exercisable, Number of Shares (in shares) | shares	35,000
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.92
Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Outstanding, Number of Shares (in shares) | shares	21,000
Stock Option Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.25
Stock Option Outstanding, Weighted Average Remaining Contractual Term (in years)	1 year 6 months 29 days
Exercisable, Number of Shares (in shares) | shares	21,000
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.25
Range of Exercise Prices, Lower Limit (in dollars per share)	1.01
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 2
Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Outstanding, Number of Shares (in shares) | shares	14,000
Stock Option Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 2.92
Stock Option Outstanding, Weighted Average Remaining Contractual Term (in years)	3 years 6 months
Exercisable, Number of Shares (in shares) | shares	14,000
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.92
Range of Exercise Prices, Lower Limit (in dollars per share)	2.01
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 3

Stock-Based Compensation (Det39

Stock-Based Compensation (Details Textual)	Sep. 09, 2011USD ($)shares	Nov. 30, 2015shares	May. 29, 2015USD ($)$ / sharesshares	Dec. 31, 2014shares	Jul. 31, 2014USD ($)$ / sharesshares	Dec. 28, 2010shares	Dec. 31, 2015USD ($)shares	Dec. 31, 2014USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Expense | $							$ 13,664	$ 28,767
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights for Employee and Non-Employee Directors							Historically, until the year ended December 31, 2014, each non-employee director of the Company was granted an option for 7,000 common shares upon first taking office, andreceived an annual option grant for an additional 7,000 common shares for each additional year in office. Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to five years from the grant date.
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term								5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate								9.59%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate								59.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate								1.71%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares								$ 0.72
Fair Value Of Restricted Shares Granted | $	$ 195,968
Fair Value Of Restricted Shares Amortization Period	15 years
Warrants to Purchase Common Stock			50,750		87,719
Warrants Exercise Price | $ / shares			$ 5.4875		$ 3.5625
Warrants Expiry Date			May 22, 2020		Jul. 28, 2019
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $			$ 54,928		$ 42,224
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised		17,550
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Of Warrants Issued To Underwriter						20,000
Exercise Price Of Warrants Issued To Underwriter						2.50
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Warrants Exercised				6,226			20,350	6,226
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Expense | $							$ 13,065	$ 13,065
Stock Issued During Period, Shares, Restricted Stock Award, Gross	1,000,000
Stock Option Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance							400,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							248,000
Share-based Compensation Arrangement By Share-based Payment Award Options Grants							376,000
Share-based Compensation Arrangement By Share-based Payment Award Options Forfeitures							224,000

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended				2 Months Ended	12 Months Ended
	Jul. 31, 2015	Jun. 30, 2015	May. 29, 2015	Jul. 31, 2014	Jun. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Class of Stock [Line Items]
Proceeds from Issuance of Common Stock, Gross					$ 4,920,000
Proceeds from Issuance of Common Stock					$ 4,240,000	$ 4,237,198	$ 4,288,765
Stock Issued During Period, Value, New Issues						4,237,198	4,288,764
Stock Issued During Period, Value, Stock Options Exercised						$ 61,190	$ 55,230
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues			1,015,000	1,754,386		1,120,000	1,754,386
Sale of Stock, Price Per Share			$ 4.39	$ 2.85
Proceeds from Issuance of Common Stock				$ 4,289,000
Stock Issued During Period, Value, New Issues			$ 4,460,000	$ 5,000,000		$ 1,120	$ 1,754
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period						40,000	66,887
Stock Issued During Period, Value, Stock Options Exercised						$ 40	$ 67
Over-Allotment Option [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period	47,250
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized			152,250	263,157
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period		105,000
Stock Issued During Period, Value, Stock Options Exercised		$ 460,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			45 days	45 days

Commitments and Contingencies (

Commitments and Contingencies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2011
Commitments and Contingencies Disclosure [Line Items]
Operating Lease Term Of Lease			five years and two months
Operating Leases, Rent Expense	$ 42,000	$ 42,000
Chief Executive Officer [Member]
Commitments and Contingencies Disclosure [Line Items]
Officers' Compensation	225,000	225,000
Officers Bonus	65,000	$ 35,000
Officers Special Bonus	30,000
Minimum [Member]
Commitments and Contingencies Disclosure [Line Items]
Operating Leases Rent Periodic Payment			$ 2,800
Operating Leases, Future Minimum Payments Due, Next Twelve Months	$ 28,100
Maximum [Member]
Commitments and Contingencies Disclosure [Line Items]
Operating Leases Rent Periodic Payment			$ 3,200